🇺🇸 Rifaximin 550 milligram Oral Tablet [XIFAXAN] in United States

Rifaximin 550 milligram Oral Tablet [XIFAXAN] (Rifaximin 550 milligram Oral Tablet [XIFAXAN]) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Rifaximin 550 milligram Oral Tablet [XIFAXAN] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rifaximin 550 milligram Oral Tablet [XIFAXAN] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rifaximin 550 milligram Oral Tablet [XIFAXAN] in United States?

Samar Atef Sebaweh Mohammed is the originator. The local marketing authorisation holder may differ — check the official source linked above.